Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 104
Filter
1.
Cambios rev. méd ; 21(1): 802, 30 Junio 2022. tabs.
Article in Spanish | LILACS | ID: biblio-1400592

ABSTRACT

INTRODUCCIÓN. La incorporación de nuevas tecnologías como la hemodiafiltración en línea, han mejorado parámetros metabólicos/nutricionales en los pacientes que se encontraban en hemodiálisis convencional; en la actualidad no existen datos registrados en la población ecuatoriana que se encuentra sometida a esta clase de tecnologías. OBJETIVO. Comparar la evolución clínico-metabólica de pacientes que estaban en hemodiálisis convencional y cambiaron a hemodiafiltración en línea, determinar si es favorable la migración de la terapia hemodialítica difusiva a convectiva y establecer si el cambio de terapia dialítica ocasionó resultados favorables. MATERIALES Y MÉTODOS. Estudio analítico retrospectivo. Población y muestra de 38 pacientes enfermos renales crónicos en terapia de sustitución renal modalidad hemodiálisis convencional que cambiaron a hemodiafiltración en línea, independientemente del tiempo de diagnóstico y tratamiento en la unidad de hemodiálisis del Hospital de Especialidades Carlos Andrade Marín, Quito-Ecuador, durante el periodo marzo 2016 a marzo 2017. RESULTADOS. Los efectos nutricionales y metabólicos pudieron denotar mayor ponderación de resultados favorables en la modalidad de hemodiafiltración. En la estabilidad hemodinámica y la dosis de diálisis se evidenció una leve superioridad en la modalidad de hemodiafiltración en comparación a la Hemodiálisis. En las dosis administradas de Calcio, Hierro, Eritropoyetina y Calcitriol no existieron diferencias significativas entre las dos modalidades de tratamientos. CONCLUSIÓN. El cambio de modalidad de Hemodiálisis convencional a Hemodiafiltración en línea fue favorable, y mejoró los parámetros clínicos/metabólicos de los pacientes que requieren terapia de sustitución renal.


INTRODUCTION. The incorporation of new technologies such as online haemodiafiltration have improved metabolic/nutritional parameters in patients who were on conventional haemodialysis; At present, there are no registered data on the Ecuadorian population that is subjected to this kind of technology. OBJECTIVE. To compare the clinical-metabolic evolution of patients who were on conventional hemodialysis and changed to online hemodiafiltration, to determine if the migration from diffusive to convective hemodialysis therapy is favorable and to establish if the change in dialysis therapy caused favorable results. MATERIALS AND METHODS. Retrospective analytical study. Population and sample of 38 patients with chronic kidney disease in conventional hemodialysis modality renal replacement therapy who changed to online hemodiafiltration, regardless of the time of diagnosis and treatment in the hemodialysis unit of the Hospital de Especialidades Carlos Andrade Marín, Quito-Ecuador, during the period March 2016 to March 2017. RESULTS. The nutritional and metabolic effects could denote a greater weighting of favorable results in the hemodiafiltration modality. In hemodynamic stability and dialysis dose, a slight superiority was evidenced in the hemodiafiltration modality compared to hemodialysis. In the administered doses of Calcium, Iron, Erythropoietin and Calcitriol there were no significant differences between the two treatment modalities. CONCLUSION. The change of modality from conventional hemodialysis to online hemodiafiltration was favorable, and improved the clinical/metabolic parameters of patients requiring renal replacement therapy.


Subject(s)
Humans , Male , Female , Ultrafiltration , Renal Dialysis , Hemodiafiltration , Continuous Renal Replacement Therapy , Hemodialysis Units, Hospital , Kidney Diseases
2.
Chinese Journal of Hepatology ; (12): 127-130, 2022.
Article in Chinese | WPRIM | ID: wpr-935923

ABSTRACT

Artificial liver is one of the effective methods to treat liver failure. Patients with liver failure are critically ill and have great individualized differences. Therefore, the specific program for the treatment of liver failure with artificial liver should be individualized. The commonly used non-biological artificial liver models include simple plasmapheresis, double filtration plasmapheresis, plasma filtration with dialysis, double plasma molecular adsorption system, molecular absorbent recirculating system, hemodiafiltration, continuous venovenous hemodiafiltration, hybrid, etc. The curative effect should be properly judged from patient's symptoms, laboratory test indicators, survival rate and other aspects after artificial liver therapy.


Subject(s)
Humans , Hemodiafiltration , Judgment , Liver Failure/therapy , Liver, Artificial , Plasmapheresis
3.
Rev. bras. ter. intensiva ; 33(1): 111-118, jan.-mar. 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1289050

ABSTRACT

RESUMO Objetivo: Avaliar a incidência de hipotermia em pacientes em terapia renal substitutiva contínua na unidade de terapia intensiva. Como objetivos secundários, determinar fatores associados e comparar a ocorrência de hipotermia entre duas modalidades de terapia renal substitutiva contínua. Métodos: Estudo de coorte, prospectivo, realizado com pacientes adultos internados em uma unidade de terapia intensiva clínico-cirúrgica, que realizaram terapia renal substitutiva contínua em um hospital universitário público de alta complexidade do Sul do Brasil, de abril de 2017 a julho de 2018. A hipotermia foi definida como queda da temperatura corporal ≤ 35ºC. Os pacientes incluídos no estudo foram acompanhados nas 48 horas iniciais de terapia renal substitutiva contínua. Os dados foram coletados pelos pesquisadores por meio da consulta aos prontuários e às fichas de registro das terapias renais substitutivas contínuas. Resultados: Foram avaliados 186 pacientes distribuídos igualmente entre dois tipos de terapia renal substitutiva contínua: hemodiálise e hemodiafiltração. A incidência de hipotermia foi de 52,7%, sendo maior nos pacientes que internaram por choque (risco relativo de 2,11; IC95% 1,21 - 3,69; p = 0,009) e nos que fizeram hemodiafiltração com aquecimento por mangueira na linha de retorno (risco relativo de 1,50; IC95% 1,13 - 1,99; p = 0,005). Conclusão: A hipotermia em pacientes críticos com terapia renal substitutiva contínua é frequente, e a equipe intensivista deve estar atenta, em especial quando há fatores de risco associados.


ABSTRACT Objective: To evaluate the incidence of hypothermia in patients undergoing continuous renal replacement therapy in the intensive care unit. As secondary objectives, we determined associated factors and compared the occurrence of hypothermia between two modalities of continuous renal replacement therapy. Methods: A prospective cohort study was conducted with adult patients who were admitted to a clinical-surgical intensive care unit and underwent continuous renal replacement therapy in a high-complexity public university hospital in southern Brazil from April 2017 to July 2018. Hypothermia was defined as a body temperature ≤ 35ºC. The patients included in the study were followed for the first 48 hours of continuous renal replacement therapy. The researchers collected data from medical records and continuous renal replacement therapy records. Results: A total of 186 patients were equally distributed between two types of continuous renal replacement therapy: hemodialysis and hemodiafiltration. The incidence of hypothermia was 52.7% and was higher in patients admitted for shock (relative risk of 2.11; 95%CI 1.21 - 3.69; p = 0.009) and in those who underwent hemodiafiltration with heating in the return line (relative risk of 1.50; 95%CI 1.13 - 1.99; p = 0.005). Conclusion: Hypothermia in critically ill patients with continuous renal replacement therapy is frequent, and the intensive care team should be attentive, especially when there are associated risk factors.


Subject(s)
Humans , Adult , Hemodiafiltration , Acute Kidney Injury/therapy , Acute Kidney Injury/epidemiology , Continuous Renal Replacement Therapy , Hypothermia/etiology , Hypothermia/epidemiology , Incidence , Prospective Studies , Critical Illness , Renal Replacement Therapy
4.
Rev. méd. Urug ; 36(1): 39-44, mar. 2020. graf
Article in Spanish | LILACS, BNUY | ID: biblio-1094225

ABSTRACT

Resumen: La enfermedad renal crónica tiene una prevalencia estimada de 6,5% a 8% en los adultos mayores de 18 años en Uruguay. A pesar de los esfuerzos por realizar un diagnóstico temprano y retrasar su progresión un porcentaje de pacientes requiere terapia de reemplazo renal (TRR) mediante diálisis, con una tasa de incidencia anual de 166 pacientes/millón de población. A pesar de las mejoras en el cuidado nefrológico y en las técnicas de hemodiálisis, la mortalidad anual de los pacientes en esta técnica es elevada en nuestro país (16,5%) y en todo el mundo. Con el objetivo de mejorar estos aspectos se han ensayado técnicas dialíticas que asocian la convección como estrategia para depurar moléculas de mayor tamaño que habitualmente no se depuran en la hemodiálisis convencional. La hemodiafiltración en línea (HDF-OL) es una técnica convectiva. Cuando se utiliza como TRR crónica se asocia a una reducción de la mortalidad de 30%-35% comparada con la hemodiálisis convencional. En el año 2014 se instrumentó esta técnica en el Hospital de Clínicas, siendo el centro pionero en el país en contar con ella como TRR crónico. El proceso de implementación implicó cambios de la infraestructura (monitores de diálisis, centro de tratamiento del agua), formación de recursos humanos, cambios en el funcionamiento y controles microbiológicos programados. El control de calidad sistemático y los diferentes estudios realizados en este período de cinco años han mostrado que es una técnica segura, capaz de remover solutos de tamaño medio y de disminuir los requerimientos de eritropoyetina. No se encuentra aún financiada por el sistema de salud, lo que puede constituir una barrera en su difusión a nivel nacional. En el presente trabajo se revisan las características fundamentales de la hemodiafiltración, su beneficio comparado con la hemodiálisis convencional, y el proceso de implementación de la técnica junto con algunos resultados iniciales en el Hospital de Clínicas.


Summary: Chronic kidney disease has an estimated prevalence of 6.5% to 8% in adults older than 18 years old in Uruguay. Despite efforts to make an early diagnosis and delay its progression, a percentage of patients require renal replacement therapy (RRT) with dialysis, the annual incidence rate being 166 patients per million population. Regardless of improvements in nephrology care and hemodialysis techniques, annual mortality ratex for this technique is high in our country (16.5%) and around the world. In order to improve these aspects, different dialysis techniques associating convection as a strategy to purify larger molecules that are rarely purified in conventional hemodialysis have been tried out. Online haemodiafiltration (OL-HDF) is a convective technique. When used as a chronic RRT it is associated to a 30-35% reduction in mortality compared to conventional hemodialysis. In 2014 this technique was introduced in the University Hospital, being it the first center that offered it as chronic renal replacement therapy. The implementation process implied changes in infrastructure (dialysis computer screens, water treatment center), the training of human resources, changes in the operation system and programmed microbiological controls. A systematic quality control and the different studies conducted in this 5-year period have proved it is a safe technique that removes average size solutes and reduces the erythropoietin requirements. This technique is still not funded by the health system, what may result in an obstacle for it to be applied nationally. This study reviews the main features of haemodiafiltration, its benefits when compared to conventional hemodialysis and the process needed to implement the technique, along with initial results in the University Hospital.


Resumo: No Uruguai a doença renal crônica tem uma prevalência estimada de 6.5 a 8% nos adultos maiores de 18 anos. Apesar dos esforços para realizar um diagnóstico precoce e retardar sua progressão uma porcentagem de pacientes requer terapia de substituição da função renal (TSFR) mediante diálise, com uma taxa de incidência anual de 166 pacientes/milhão de habitantes. Independentemente das melhorias na atenção nefrológica e nas técnicas de hemodiálise, a mortalidade anual dos pacientes em tratamento com esta técnica é elevada no Uruguai (16.5%) e no mundo todo. Buscando melhorar esses aspectos foram ensaiadas varias técnicas dialíticas que associam a convecção como estratégia para depurar moléculas de maior tamanho que habitualmente não são depuradas na hemodiálise convencional. A hemodiafiltração on line (HDF-OL) é uma técnica convectiva. Quando é utilizada como TSFR crônica está associada a uma redução da mortalidade de 30-35% comparada com a hemodiálise convencional. Esta técnica foi instrumentada em 2014 no Hospital de Clínicas, sendo este o centro pioneiro no Uruguai em utilizá-la como TSFR crônico. O processo de implementação impôs mudanças na infraestrutura (monitores de diálise, centro de tratamento da água), formação de Recursos Humanos e mudanças no funcionamento e controles microbiológicos programados. O controle de qualidade sistemático e os diferentes estudos realizados neste período de 5 anos mostraram que é uma técnica segura, capaz de remover solutos de tamanho médio e de reduzir os requerimentos de eritropoietina. A atual falta de financiamento pelo sistema de saúde pode ser uma barreira para sua difusão no país. Neste trabalho faz-se uma revisão das características fundamentais da hemodiafiltração, seu beneficio comparado com a hemodiálise convencional, o processo de implementação da técnica e alguns resultados iniciais do Hospital de Clínicas.


Subject(s)
Hemodiafiltration , Renal Insufficiency, Chronic
5.
J. bras. nefrol ; 41(2): 224-230, Apr.-June 2019. tab, graf
Article in English | LILACS | ID: biblio-1012538

ABSTRACT

Abstract Introduction: Hyperphosphatemia is a serious consequence of chronic kidney disease and has been associated with an increased risk for cardiovascular disease. Controlling serum phosphorus levels in patients on dialysis is a challenge for the clinicians and implies, in most cases, the use of phosphate binders (PB). Part of the reason for this challenge is poor adherence to treatment because of the high pill burden in this patient group. Objective: To assess the real-world effectiveness of sucroferric oxyhydroxide (SO) in controlling serum phosphorus levels and determine the associated pill burden. Methods: A multicenter, quantitative, retrospective, before-after study was conducted with patients receiving online hemodiafiltration. Patients who switched to SO as a part of routine care were included in the study. PB treatment, number of pills, serum phosphorus levels, and intravenous iron medication and dosage were collected monthly during the six months of treatment with either PB or SO. Results: A total of 42 patients were included in the study. After switching from a PB to SO, the prescribed pills/day was reduced 67% from 6 pills/day to 2 pills/day (p < 0.001) and the frequency of pill intake was lowered from 3 times/day to 2 times/day (p < 0.001). During the treatment with SO, the proportion of patients with serum phosphorus ≤ 5.5 mg/dL increased from 33.3% at baseline to 45% after six months of treatment. Conclusion: During the six-month follow-up with SO, serum phosphorus levels were controlled with one third of the pills/day compared to other PB.


Resumo Introdução: A hiperfosfatemia é uma grave consequência da doença renal crônica associada a risco aumentado de doença cardiovascular. O controle dos níveis séricos de fósforo dos pacientes em diálise é um desafio que requer, na maioria dos casos, o uso de quelantes de fosfato (QF). Parte da dificuldade se deve à baixa adesão ao tratamento oriunda do grande número de medicamentos receitados para esse grupo de pacientes. Objetivo: Avaliar a real eficácia do oxihidróxido sucroférrico (OHS) no controle dos níveis séricos de fósforo e determinar a carga de comprimidos associada. Métodos: Estudo multicêntrico, quantitativo, retrospectivo, antes e depois conduzido com pacientes em hemodiafiltração on-line. Pacientes remanejados para OHS como parte dos cuidados de rotina foram incluídos no estudo. Tratamento com QF, número de comprimidos, níveis séricos de fósforo, reposição férrica endovenosa e dosagens foram registrados mensalmente durante seis meses de tratamento com QF ou OHS. Resultados: Foram incluídos 42 pacientes no estudo. Após a mudança de QF para OHS, o número de comprimidos prescritos por dia caiu em 67%, de seis para duas unidades diárias (p < 0,001). A frequência de ingestão de comprimidos caiu de três para duas vezes ao dia (p < 0,001). Durante o tratamento com OHS, o percentual de pacientes com fósforo sérico ≤ 5,5 mg/dL aumentou de 33,3% no início para 45% após seis meses de tratamento. Conclusão: Durante os seis meses de seguimento com OHS, os níveis séricos de fósforo foram controlados com um terço dos comprimidos por dia em relação aos tratamentos com outros QF.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Sucrose/therapeutic use , Ferric Compounds/therapeutic use , Hemodiafiltration , Hyperphosphatemia/drug therapy , Phosphorus/blood , Retrospective Studies , Follow-Up Studies , Treatment Outcome , Drug Combinations , Renal Insufficiency, Chronic/complications , Hyperphosphatemia/etiology , Medication Adherence , Sevelamer/adverse effects , Sevelamer/therapeutic use
7.
Rev. méd. Chile ; 147(4): 409-415, abr. 2019. tab
Article in Spanish | LILACS | ID: biblio-1014241

ABSTRACT

Background: In critical patients with acute renal failure, intermittent diffusive renal replacement techniques cause hemodynamic problems due to their high depurative efficiency. This situation is avoided using continuous low efficiency therapies, which are expensive, prevent patient mobilization and add hemorrhagic risk due to systemic anticoagulation. Intermittent and prolonged hemodiafiltration (HDF) has the depurative benefits of diffusion, plus the positive attributes of convection in a less expensive therapy. Aim: To report our experience with intermittent and prolonged on-line HDF in critically ill patients. Patients and Methods: During 2016, HDF therapies performed on critical patients with indication of renal replacement therapy were characterized. The hemodynamic profile was evaluated (doses of noradrenaline, blood pressure, heart rate and perfusion parameters). Results: Fifty-one therapies were performed in 25 critical patients, aged 58 ± 11 years (28% women), with an APACHE II score of 22.1 ±10. The average time of the therapies was 4.15 hours (range 3-8 hours), the replacement volume was 75 ± 18 mL/kg/h and ultrafiltration rate was 226 ± 207 mL/h. The mean initial, maximum and final noradrenaline doses were 0.07 ± 0.1, 0.13 ±0.18 and 0.09 ±0.16 μg/kg/min respectively. No differences between patients with low, medium and high doses of noradrenaline or dose increases during therapy, were observed. The greatest decrease in mean arterial pressure was 15.3% and the maximum increase in heart rate was 12.8%. Anticoagulation was not required in 88% of therapies. Conclusions: High-volume intermittent or prolonged HDF is an effective therapy in critical patients, with good hemodynamic tolerability, lower costs and avoidance of systemic anticoagulation risks.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Critical Illness/therapy , Renal Replacement Therapy/methods , Hemodiafiltration/methods , Acute Kidney Injury/therapy , Norepinephrine/administration & dosage , Prospective Studies , Analysis of Variance , Treatment Outcome , APACHE , Hemodynamics
8.
Einstein (Säo Paulo) ; 17(1): eAO4439, 2019. tab
Article in English | LILACS | ID: biblio-984372

ABSTRACT

ABSTRACT Objective To investigate the impacts of continuous venovenous hemodiafiltration on the microcirculation in patients with acute kidney injury. Methods A prospective observational pilot study conducted in a 40-bed, open clinical-surgical intensive care unit of a private tertiary care hospital located in the city of São Paulo (SP), Brazil. Microcirculation was assessed using near-infrared spectroscopy by means of a 15mm probe placed over the thenar eminence. Vascular occlusion test was performed on the forearm to be submitted to near-infrared spectroscopy by inflation of a sphygmomanometer cuff to 30mmHg higher than the systolic arterial pressure. The primary endpoint was the assessment of near-infrared spectroscopy-derived parameters immediately before, 1, 4 and 24 hours after the initiation of continuous venovenous hemodiafiltration. Results Nine patients were included in this pilot study over a period of 2 months. Minimum tissue oxygen saturation measured during the vascular occlusion test was the only near-infrared spectroscopy-derived parameter to differed over the time (decrease compared to baseline values up to 24 hours after initiation of continuous venovenous hemodiafiltration). Conclusion The impacts of microcirculatory dysfunction on clinical outcomes of patients undergoing to continuous venovenous hemodiafiltration need to be further investigated.


RESUMO Objetivo Avaliar o impacto da hemodiafiltração venovenosa contínua na microcirculação de pacientes com lesão renal aguda. Métodos Estudo piloto, prospectivo e observacional conduzido em uma unidade de terapia intensiva clínico-cirúrgica aberta, com 40 leitos, localizada em um hospital terciário, privado, na cidade de São Paulo (SP), Brasil. A microcirculação foi avaliada empregando-se a espectroscopia no infravermelho próximo, por meio de uma sonda de 15mm posicionada sobre a eminência tenar. O teste de oclusão vascular foi realizado no antebraço a ser submetido à espectroscopia no infravermelho próximo, inflando-se o manguito de um esfigmomanômetro a um valor 30mmHg acima da pressão arterial sistólica. O desfecho primário foi a avaliação dos parâmetros derivados por espectroscopia no infravermelho próximo imediatamente antes, 1, 4 e 24 horas após o início da hemodiafiltração venovenosa contínua. Resultados Foram incluídos nove pacientes neste estudo piloto ao longo de 2 meses. A saturação de oxigênio tecidual mínima mensurada durante o teste de oclusão vascular foi o único parâmetro derivado por espectroscopia no infravermelho próximo que diferiu ao longo do tempo, com queda em relação aos valores iniciais nas primeiras 24 horas após o início da hemodiafiltração venovenosa contínua. Conclusão A influência da disfunção microcirculatória sobre os desfechos clínicos de pacientes submetidos à hemodiafiltração venovenosa contínua precisa ser melhor investigada.


Subject(s)
Humans , Male , Female , Hemodiafiltration/methods , Acute Kidney Injury/diagnostic imaging , Microcirculation/physiology , Pilot Projects , Prospective Studies , Spectroscopy, Near-Infrared , Acute Kidney Injury/physiopathology , Acute Kidney Injury/therapy , Middle Aged
9.
Kidney Research and Clinical Practice ; : 159-168, 2019.
Article in English | WPRIM | ID: wpr-758994

ABSTRACT

The life expectancy of end-stage renal disease patients undergoing regular hemodialysis (HD) remains significantly lower than in the general population. Reducing excess mortality by improving renal replacement options is an unmet medical need. Online post-dilution hemodiafiltration (HDF) has been promoted as the gold standard, offering improved clinical outcomes, based on numerous observational studies that suggest a reduced mortality risk and lower morbidity with HDF compared with standard HD. However, most randomized controlled trials (RCTs) have failed to demonstrate a significant beneficial effect of HDF on all-cause mortality. The effects on secondary outcomes were often negligible or absent. Unfortunately, these RCTs were characterized by a moderate to high risk of bias. In post-hoc analyses of the largest RCTs and meta-analysis of individual participant data from four RCTs, HDF patients receiving the highest convection volume consistently and dose-dependently saw superior outcomes. However, as these studies were not designed a priori to clarify this issue, and there are no indisputable mechanisms underlying reduced mortality risks, we cannot exclude the possibility that the health status of patients (with vascular access as a proxy) may affect outcomes more than the convective technique itself. There is currently insufficient evidence to support the contention that high-volume HDF confers relevant benefits to patients over standard HD. The conflicting data of published RCTs reduce confidence in the superiority of high-volume convective therapy. Hopefully, ongoing large RCTs (for example, CONVINCE) may supply an indisputable answer to the crucial question of high-volume HDF.


Subject(s)
Humans , Bias , Convection , Hemodiafiltration , Kidney Failure, Chronic , Life Expectancy , Mortality , Renal Dialysis
10.
Porto Alegre; s.n; 2018. 15 p.
Thesis in Portuguese | LILACS, ColecionaSUS | ID: biblio-967887

ABSTRACT

Diante da fisiopatologia da Insuficiência Renal Aguda e o aumento da necessidade de algum método de terapia de substituição renal nas Unidades de Terapia Intensiva (UTI) demandando expressiva atuação do enfermeiro, encontrou-se a necessidade de realizar este estudo. Objetivo: o objetivo geral foi estudar as publicações a respeito da terapia de substituição renal contínua. A metodologia deste estudo foi uma revisão bibliográfica integrativa, em base documental de natureza qualitativa, cujos dados foram coletados através do levantamento das produções científicas sobre terapia dialítica contínua, produzidas entre os anos de 2012 a 2017. Os descritores utilizados foram: Diálise renal, Diálise, Unidades hospitalares de diálise renal e Hemodiafiltração, nas bases de dados Biblioteca Virtual em Saúde, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Scientific Electronic Library Online e Web of Science. Resultados: 100% dos artigos foram publicados em periódicos internacionais, com participação médica e de natureza quantitativas. Os assuntos abordados nos estudos foram: A influência de macro e micronutrientes na lesão renal aguda, desfechos renais em pacientes que utilizaram terapia de substituição renal, configurações de fluxo de dialisato, expectativas de médicos, enfermeiros e pacientes sobre a recuperação de pacientes que necessitam de terapia de substituição renal, estabilidade hemodinâmica de pacientes tratados com diálise de baixa eficiência sustentada usando um sistema de diálise de batimento de passagem única (SLED-BD) e aumento de velocidade da bomba de sangue gradual. Conclusão: Conclui-se que a avaliação da efetividade da terapia dialítica, nutrição, qualidade de acesso vascular, integridade dos filtros dialisadores e fluxos mínimos são necessários para o sucesso da terapia e segurança do paciente. É importante ....(AU)


Subject(s)
Humans , Male , Female , Unified Health System , Brazil , Public Health , Hemodiafiltration , Nursing Care
11.
Archives of Plastic Surgery ; : 375-378, 2018.
Article in English | WPRIM | ID: wpr-715679

ABSTRACT

In this report, we present a case of successful treatment of a bowel fistula in the open abdomen by perforator flaps and an aponeurosis plug. A 70-year-old man underwent total gastrectomy and developed anastomotic leakage and dehiscence of the abdominal wound a week later. He was dependent upon extracorporeal membrane oxygenation, continuous hemodiafiltration, and a respirator. Bowel fluids contaminated the open abdomen. Two months after the gastric operation, a plastic surgery team, in consultation with general surgeons, performed perforator flaps on both sides and constructed, as it were, a bridge of skin sealing the orifice of the fistula. The aponeurosis of the external oblique muscle was elevated with the flap to be used as a plug. The perforators of the flaps were identified on preoperative and intraoperative ultrasonography. This modality allowed us to locate the perforators precisely and to evaluate the perforators by assessing their diameters and performing a waveform analysis. The contamination decreased dramatically afterwards. The bare areas were gradually covered by skin grafts. The fistula was closed completely 18 days after the perforator flap. An ultrasoundguided perforator flap with an aponeurosis plug can be an option for patients suffering from an open abdomen with a bowel fistula.


Subject(s)
Aged , Humans , Abdomen , Abdominal Wound Closure Techniques , Anastomotic Leak , Extracorporeal Membrane Oxygenation , Fistula , Gastrectomy , Hemodiafiltration , Intestinal Fistula , Perforator Flap , Skin , Surgeons , Surgery, Plastic , Transplants , Ultrasonography , Ultrasonography, Doppler , Ventilators, Mechanical , Wounds and Injuries
12.
Rev. nefrol. diál. traspl ; 37(4): 191-197, dic. 2017. tab, graf
Article in Spanish | LILACS | ID: biblio-1006563

ABSTRACT

INTRODUCCIÓN: La hemodiafiltración en línea de alto volumen (HVHDF) es una técnica eficaz que permite la remoción de toxinas urémicas de mayor PM debido al transporte convectivo. Esta modalidad permite mayor estabilidad hemodinámica, disminución de los parámetros inflamatorios y reducción de la mortalidad cardiovascular y por todas las causas comparada con la hemodiálisis (HD). Estos beneficios se producen cuando los volúmenes de sustitución (VS) son mayores a 21 L/sesión de allí la denominación de hemodiafiltración de alto volumen. OBJETIVOS: Evaluar la eficacia de la HVHDF en comparación con HD y determinar si el cambio de modalidad se asocia a mayor estabilidad hemodinámica, mejoría en los resultados de laboratorio, en la cantidad de hospitalizaciones y en la calidad de vida. MATERIAL Y MÉTODOS: Estudio retrospectivo, observacional, en único centro que incluyó 53 pacientes, que completaron 6 meses de HVHDF luego de haber realizado al menos 6 meses de HD. Se analizaron datos demográficos, episodios de hipotensión, número y días de internación tanto en HD como en HVHDF. Se compararon: Hemoglobina (Hb), fósforo (P), parathormona intacta (PTHi), albúmina (alb), proteína C reactiva (PCR), KTV, y dosis de eritropoyetina durante el último mes de HD y sexto mes de HVHDF. Se analizó la encuesta sobre calidad de vida Kidney Disease Quality of Life-36 (KDQOL-36) al inicio y a los 6 meses de HVHDF. RESULTADOS: LA edad media fue de 60,6 años, el 67.9 % eran hombres. La FAV fue el acceso vascular en el 69.8% de los pacientes, mientras que 38 pacientes (71,1%) cumplían con volumen de sustitución > 21 litros/sesión. El 39,6 % presentó algún episodio de hipotensión en HD y 30.2 % lo hizo en HVHDF (p<0.001). El número de episodios de hipotensión fue significativamente mayor en hemodiálisis que en HVHDFL, 40 (18-68) vs 11 (3-33) (p< 0.001). El 32% de pacientes en HD requirió internación y sólo el 11% en HVHDF. Hubo mejoría significativa en la Hb: 10.7 a 11.3 (p<0.01), KTV: 1.4 a 1.5 (p<0.03) y menor requerimiento de EPO (p< 0,02) al 6° mes de HVHDF. En la encuesta de calidad de vida, KDQOL-36, se observó mejoría en el módulo, síntomas problemas, siendo estadísticamente significativo, adicionándose mejoría en short form 12 (SF) físico y mental sólo en los pacientes con volúmenes de sustitución > 21l/sesión. CONCLUSIÓN: En nuestra cohorte el cambio de HD a HVHDF se asoció a una disminución en el número de episodios de hipotensión, reflejando una mayor estabilidad hemodinámica, menor número de internaciones, una mejoría en la hemoglobina, KTV y disminución de dosis semanal de eritropoyetina


INTRODUCTION: High-volume online hemodiafiltration (HV-OL-HDF) is an effective technique to remove uremic toxins with higher molecular weight through convective transport. In correlation with hemodialysis (HD), through this method, greater hemodynamic stability, lower inflammatory parameters and a smaller risk of death due to cardiovascular or any other factors are achieved. These benefits are obtained when substitution volume (SV) is higher than 21L/session; that is the reason why the technique is called high-volume hemodiafiltration (HVHDF). OBJECTIVES: To assess the effectiveness of HVHDF as compared to HD and to determine if changing the type of therapy results in greater hemodynamic stability, better lab test results, a lower number of hospital admissions and a superior quality of life. METHODS: This retrospective observational study was conducted in only one center and included 53 patients who underwent HVHDF during 6 months after having hemodialysis (HD) for at least 6 months. We analyzed demographic variables, number of hypotension events, number of hospital admissions, and length of stay for each type of treatment. The following were compared: hemoglobin (Hb), phosphate (P), intact parathormone (iPTH), albumin (ALB), C-reactive protein (CRP), Kt/V and erythropoietin dose during the last month of HD and the sixth month of HVHDF. The Kidney Disease Quality of Life-36 (KDQOL-36™) questionnaire was completed at the beginning and after 6 months of HVHDF. RESULTS: The average age was 60.6 years old and 67.9% of the participants were men. The vascular access was created using an arteriovenous fistula in 69.8% of patients and 38 of them (71.1%) had substitution volume of > 21L/session. Some patients (39.6 %) experienced a hypotension event during HD and others (30.2%) during HVHDF (p<0.001). The number of hypotension events was significantly higher in patients treated with HD than in patients treated with HV-OL-HDF: 40 (18-68) vs. 11 (3-33) (p< 0.001). The percentage of patients admitted to hospital was the following: 32% for HD and 11% for HVHDF. A considerable improvement was observed in Hb (10.7 to 11.3 [p<0.01]) and Kt/V (1.4 to 1.5 [p<0.03]; a lower dose of EPO was needed after 6 months of HVHDF (p< 0.02). Only patients with substitution volume of > 21L/session showed statistically significant improvement in the symptoms/problems section of KDQOL-36 and in the Short Form-12 (SF-12) Physical and Mental Health Summary. CONCLUSION: When changing from HD to HVHDF, our study group had a lower number of hypotension events; greater hemodynamic stability; a smaller number of hospital admissions; better Hb levels and Kt/V, and they needed a lower dose of erythropoietin


Subject(s)
Humans , Biomarkers , Hemodiafiltration , Hemodynamics , Kidney Failure, Chronic
13.
Journal of Zhejiang University. Medical sciences ; (6): 598-606, 2016.
Article in Chinese | WPRIM | ID: wpr-300841

ABSTRACT

To investigate the role of glucose transporter 1 (GLUT1) and sodium-glucose cotransporter 1 (SGLT1) in high glucose dialysate-induced peritoneal fibrosis.Thirty six male SD rats were randomly divided into 6 groups (6 in each):normal control group, sham operation group, peritoneal dialysis group (PD group), PD+phloretin group (PD+T group), PD+phlorizin group (PD+Z group), PD+phloretin+phlorizin group (PD+T+Z group). Rat model of uraemia was established using 5/6 nephrotomy, and 2.5% dextrose peritoneal dialysis solution was used in peritoneal dialysis. Peritoneal equilibration test was performed 24 h after dialysis to evaluate transport function of peritoneum in rats; HE staining was used to observe the morphology of peritoneal tissue; and immunohistochemistry was used to detect the expression of GLUT1, SGLT1, TGF-β1 and connective tissue growth factor (CTGF) in peritoneum. Human peritoneal microvascular endothelial cells (HPECs) were divided into 5 groups:normal control group, peritoneal dialysis group (PD group), PD+phloretin group (PD+T group), PD+phlorezin group (PD+Z group), and PD+phloretin+phlorezin group (PD+T+Z group). Real time PCR and Western blotting were used to detect mRNA and protein expressions of GLUT1, SGLT1, TGF-β1, CTGF in peritoneal membrane and HPECs., compared with sham operation group, rats in PD group had thickened peritoneum, higher ultrafiltration volume, and the mRNA and protein expressions of GLUT1, SGLT1, CTGF, TGF-β1 were significantly increased (all<0.05); compared with PD group, thickened peritoneum was attenuated, and the mRNA and protein expressions of GLUT1, SGLT1, CTGF, TGF-β1 were significantly decreased in PD+T, PD+Z and PD+T+Z groups (all<0.05). Pearson's correlation analysis showed that the expressions of GLUT1, SGLT1 in peritoneum were positively correlated with the expressions of TGF-β1 and CTGF (all<0.05)., the mRNA and protein expressions of GLUT1, SGLT1, TGF-β1, CTGF were significantly increased in HPECs of peritoneal dialysis group (all<0.05), and those in PD+T, PD+Z, and PD+T+Z groups were decreased (all<0.05). Pearson's correlation analysis showed that the expressions of GLUT1, SGLT1 in HPECs were positively correlated with the expressions of TGF-β1 and CTGF (all<0.05).High glucose peritoneal dialysis fluid may promote peritoneal fibrosis by upregulating the expressions of GLUT1 and SGLT1.


Subject(s)
Animals , Humans , Male , Rats , Cells, Cultured , Connective Tissue Growth Factor , Dialysis Solutions , Chemistry , Pharmacology , Gene Expression Regulation , Glucose , Pharmacology , Glucose Transporter Type 1 , Physiology , Hemodiafiltration , Methods , Peritoneal Dialysis , Methods , Peritoneal Fibrosis , Genetics , Peritoneum , Chemistry , Pathology , Phloretin , Phlorhizin , RNA, Messenger , Rats, Sprague-Dawley , Sodium-Glucose Transporter 1 , Physiology , Transforming Growth Factor beta1 , Uremia
14.
Journal of Central South University(Medical Sciences) ; (12): 1334-1339, 2016.
Article in Chinese | WPRIM | ID: wpr-815088

ABSTRACT

To evaluate the safety and efficiency of citrate anticoagulant-based continuous blood purification in patients at high risk of bleeding. 
 Methods: One hundred and fifty-two patients at high risk of bleeding were divided into local citrate group (group A, n=68) and heparin group (group B, n=84). Clotting function, change of pH, ionized sodium, bicarbonate ion, ionized calcium, activated clotting time (ACT) and complications were monitored before and during treatment. 
 Results: Compared to the group A, the incidence of clotting in filter and chamber, the degree of bleeding or fresh bleeding were significantly reduced in the group B (P0.05). The pH value, the levels of ionized sodium, bicarbonate ion and ionized calcium during the treatment were maintained in normal range in both group A and group B.
 Conclusion: Local citrate-based continuous blood purification can achieve effective anticoagulation and decrease the incidence of bleeding. It is an ideal choice for patients at high risk of bleeding.


Subject(s)
Female , Humans , Male , Anticoagulants , Pharmacology , Bicarbonates , Blood , Blood Coagulation , Blood Coagulation Tests , Calcium , Blood , Citrates , Citric Acid , Therapeutic Uses , Hemodiafiltration , Methods , Hemofiltration , Hemorrhage , Heparin , Therapeutic Uses , Intensive Care Units , Reference Values , Renal Dialysis , Sodium , Blood , Treatment Outcome
15.
Electrolytes & Blood Pressure ; : 1-4, 2016.
Article in English | WPRIM | ID: wpr-145687

ABSTRACT

Conventional hemodialysis, which is based on the diffusive transport of solutes, is the most widely used renal replacement therapy. It effectively removes small solutes such as urea and corrects fluid, electrolyte and acid-base imbalance. However, solute diffusion coefficients decreased rapidly as molecular size increased. Because of this, middle and large molecules are not removed effectively and clinical problem such as dialysis amyloidosis might occur. Online hemodiafiltration which is combined by diffusive and convective therapies can overcome such problems by removing effectively middle and large solutes. Online hemodiafiltration is safe, very effective, economically affordable, improving session tolerance and may improve the mortality superior to high flux hemodialysis. However, there might be some potential limitations for setting up online hemodiafiltaration. In this article, we review the uremic toxins associated with dialysis, definition of hemodiafiltration, indication and prescription of hemodiafiltration and the limitations of setting up hemodiafiltration.


Subject(s)
Acid-Base Imbalance , Amyloidosis , Dialysis , Diffusion , Hemodiafiltration , Mortality , Prescriptions , Renal Dialysis , Renal Replacement Therapy , Urea , Water
16.
Kidney Research and Clinical Practice ; : 187-189, 2016.
Article in English | WPRIM | ID: wpr-198724

ABSTRACT

A 65-year-old man was transferred from the Department of Vascular Surgery to Nephrology because of cardiac arrest during hemodialysis. He underwent incision and drainage for treatment of a buttock abscess. Nafamostat mesilate was used as an anticoagulant for hemodialysis to address bleeding from the incision and drainage site. Sudden cardiac arrest occurred after 15 minutes of dialysis. The patient was treated in the intensive care unit for 5 days. Continuous veno-venous hemodiafiltration was started without any anticoagulant in the intensive care unit. Conventional hemodialysis was reinitiated, and nafamostat mesilate was used again because of a small amount of continued bleeding. Ten minutes after hemodialysis, the patient complained of anaphylactic signs and symptoms such as dyspnea, hypotension, and facial swelling. Epinephrine, dexamethasone, and pheniramin were injected under the suspicion of anaphylactic shock, and the patient recovered. Total immunoglobulin E titer was high, and skin prick test revealed weak positivity for nafamostat mesilate. We first report a case of anaphylactic shock caused by nafamostat mesilate in Korea.


Subject(s)
Aged , Humans , Abscess , Anaphylaxis , Buttocks , Death, Sudden, Cardiac , Dexamethasone , Dialysis , Drainage , Dyspnea , Epinephrine , Heart Arrest , Hemodiafiltration , Hemorrhage , Hypotension , Immunoglobulin E , Immunoglobulins , Intensive Care Units , Korea , Mesylates , Nephrology , Renal Dialysis , Skin
17.
Rev. bras. ter. intensiva ; 27(4): 402-405, out.-dez. 2015. tab, graf
Article in English | LILACS | ID: lil-770051

ABSTRACT

RESUMO A hipercalcemia é um distúrbio metabólico raro em pediatria, potencialmente fatal, apresentando um vasto diagnóstico diferencial, incluindo neoplasias. Relatamos aqui o caso de uma criança de 3 anos, previamente saudável, admitida no serviço de urgência por fadiga, hiporreatividade, febre e claudicação da marcha com 5 dias de evolução, de agravamento progressivo. À observação, apresentava-se inconsciente (escore de coma Glasgow: 8). Laboratorialmente, apresentava hipercalcemia grave (cálcio total 21,39mg/dL, ionizado 2,93mmol/L) e anemia microcítica. Iniciou hiper-hidratação e foi transferido para a unidade de cuidados intensivos pediátricos. Instituiu-se hemodiafiltração venovenosa contínua com soluto livre de cálcio, ocorrendo a progressiva normalização da calcemia, com melhoria do estado de consciência. Administrou-se zolendronato. Excluíram-se causas metabólicas, infecciosas e intoxicação. O mielograma permitiu o diagnóstico de leucemia linfoblástica aguda. A hipercalcemia associada à malignidade em pediatria é rara, ocorrendo como forma de apresentação da neoplasia ou na recorrência desta. Em situações com risco de vida iminente, deve se considerar hemodiafiltração venovenosa contínua.


ABSTRACT Hypercalcemia is a rare metabolic disorder in children and is potentially fatal. It has a wide differential diagnosis, including cancer. Here, we report the case of a previously healthy 3-year-old who was admitted to the emergency room with fatigue, hyporeactivity, fever and limping gait that had evolved over 5 days and that was progressively worsening. On examination the patient was unconscious (Glasgow coma score: 8). Laboratory tests indicated severe hypercalcemia (total calcium 21.39mg/dL, ionized calcium 2.93mmol/L) and microcytic anemia. Hyperhydration was initiated, and the child was transferred to the pediatric intensive care unit. Continuous venovenous hemodiafiltration with calcium-free solution was instituted, which brought progressive normalization of serum calcium and an improved state of consciousness. Zoledronate was administered, and metabolic and infectious causes and poisoning were excluded. The bone marrow smear revealed a diagnosis of acute lymphoblastic leukemia. Hypercalcemia associated with malignancy in children is rare and occurs as a form of cancer presentation or recurrence. Continuous venovenous hemodiafiltration should be considered in situations where there is imminent risk to life.


Subject(s)
Humans , Male , Child, Preschool , Hemodiafiltration/methods , Williams Syndrome/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Diphosphonates/therapeutic use , Bone Density Conservation Agents/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Zoledronic Acid , Hypercalcemia/therapy , Imidazoles/therapeutic use
18.
Kidney Research and Clinical Practice ; : 132-139, 2015.
Article in English | WPRIM | ID: wpr-179041

ABSTRACT

The Korean Society of Nephrology (KSN) launched a nationwide official survey program about dialysis therapy in 1985. Nowadays, the accumulated data for 30 years by this "Insan Prof. Min Memorial end-stage renal disease (ESRD) Registry" program have been providing the essential information for dialysis clinical practice, academic nephrology research, and health management policy. We reviewed 30 years of data to identify important changes and implications for the future improvement of dialysis therapy in Korea. Hemodialysis patients, especially diabetics and elderly patients have increased in number very rapidly during recent years in Korea. The Korean prevalence rate of ESRD patients was about 70% of the United States and about 50% of Japan according to the international comparisons in the annual data report of United States Renal Data System. The blood pressure control, anemia control, and dialysis adequacy have continuously improved year by year. The importance of calcium and phosphorus control has also been increasing because of the increase in long-term dialysis patients. In addition, chronic dialysis complications should be closely monitored and dialysis modifications, such as hemodiafiltration therapy, might be considered. Because of the increase of private clinics and nursing hospitals in dialysis practice, the role of dialysis specialists and continuing education are thought to be essential. For strict cost-effective dialysis control of increasing elderly, diabetic, and long-term dialysis patients, the KSN ESRD patient registration should be run by the KSN and health ministry in cooperation, in which the dialysis fee reimbursement should be accompanied.


Subject(s)
Aged , Humans , Anemia , Blood Pressure , Calcium , Dialysis , Education, Continuing , Fees and Charges , Hemodiafiltration , Information Systems , Japan , Kidney Failure, Chronic , Korea , Nephrology , Nursing , Peritoneal Dialysis , Phosphorus , Prevalence , Renal Dialysis , Specialization , United States
19.
Journal of the Korean Society of Emergency Medicine ; : 480-482, 2015.
Article in English | WPRIM | ID: wpr-145518

ABSTRACT

Diabetic ketoacidosis (DKA) is a complex medical disorder characterized by abnormalities in electrolyte, acid-base, and volume status. Metabolic acidosis in mild and moderate DKA is corrected with insulin therapy. Bicarbonate therapy may be indicated in cases of severe metabolic acidosis, however the use of bicarbonate in severe DKA is controversial due to a lack of prospective randomized studies. Renal replacement therapy can be used for correction of systemic acidemia. Continuous renal replacement therapy (CRRT) is used in patients who are too hemodynamically unstable to tolerate conventional hemodialysis, but has also been used in treatment of patients with severe DKA. CRRT has never been used previously in DKA patients with refractory metabolic acidosis in Korea. Here, we describe the successful treatment of a DKA patient with refractory metabolic acidosis with CRRT.


Subject(s)
Humans , Acidosis , Diabetic Ketoacidosis , Hemodiafiltration , Insulin , Korea , Prospective Studies , Renal Dialysis , Renal Replacement Therapy
20.
Yeungnam University Journal of Medicine ; : 17-21, 2015.
Article in Korean | WPRIM | ID: wpr-85005

ABSTRACT

Amlodipine, a calcium channel blocker of the dihydropyridine group, is commonly used in management of hypertension, angina, and myocardial infarction. Amlodipine overdose, characterized by severe hypotension, arrythmias, and pulmonary edema, has seldom been reported in Korean literature. We report on a fatal case of amlodipine intoxication with complications including rhabdomyolysis and oliguric acute kidney injury. A 70-year-old woman with a medical history of hypertension was presented at the author's hospital 6 hours after ingestion of 50 amlodipine (norvasc) tablets (total dosage 250 mg) in an attempted suicide. Her laboratory tests showed a serum creatinine level of 2.5 mg/dL, with elevated serum creatine phosphokinase and myoglobin. The patient was initially treated with fluids, alkali, calcium gluconate, glucagon, and vasopressors without a hemodynamic effect. High-dose insulin therapy was also started with a bolus injection of regular insulin (RI), followed by continuous infusion of RI and 50% dextrose with water. Despite intensive treatment including insulin therapy, inotropics, mechanical ventilation, and continuous venovenous hemodiafiltration, the patient died of refractory shock and cardiac arrest with no signs of renal recovery 116 hours after her hospital admission.


Subject(s)
Aged , Female , Humans , Acute Kidney Injury , Alkalies , Amlodipine , Arrhythmias, Cardiac , Calcium Channels , Calcium Gluconate , Creatine Kinase , Creatinine , Eating , Glucagon , Glucose , Heart Arrest , Hemodiafiltration , Hemodynamics , Hypertension , Hypotension , Insulin , Myocardial Infarction , Myoglobin , Pulmonary Edema , Respiration, Artificial , Rhabdomyolysis , Shock , Suicide, Attempted , Tablets , Water
SELECTION OF CITATIONS
SEARCH DETAIL